ITGR

Integer Holdings Corporation NYSE

Healthcare ·Medical - Devices ·US · integer.net

$84.03

Mkt Cap $3.0B

52w Low $62.00 33.9% of range 52w High $127.06

50d MA $85.90 200d MA $89.53

P/E (TTM) 28.4x

EV/EBITDA 13.7x

P/B 1.7x

Debt/Equity 0.8x

ROE 5.9%

P/FCF 25.9x

RSI (14) —

ATR (14) —

Beta 0.71

50d MA $85.90

200d MA $89.53

Avg Volume 784.3K

About

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	BMO	1.21	1.20	-0.8%	83.67	-7.9%	+5.8%	+0.4%	—	—	—	—	—
Feb 19, 2026	BMO	1.70	1.76	+3.5%	86.48	+15.6%	-4.0%	-1.9%	-0.8%	+0.7%	+0.0%	-1.3%	—
Oct 23, 2025	BMO	1.68	1.79	+6.5%	109.11	-20.1%	-32.3%	-33.2%	-35.7%	-37.7%	-40.2%	-34.7%	—
Jul 24, 2025	BMO	1.57	1.55	-1.3%	115.77	-3.2%	-7.5%	-6.3%	-6.6%	-5.7%	-6.1%	-6.0%	—
Apr 24, 2025	BMO	1.27	1.31	+3.1%	120.51	+3.1%	+0.8%	+2.4%	+1.9%	+5.3%	+4.8%	+0.9%	—
Feb 20, 2025	BMO	1.46	1.43	-2.1%	143.21	-0.8%	-5.6%	-9.3%	-11.3%	-10.8%	-11.8%	-18.2%	—
Oct 24, 2024	BMO	1.36	1.43	+5.1%	126.53	-4.1%	+0.2%	-0.6%	+1.1%	+2.8%	+2.7%	+10.9%	—
Jul 25, 2024	BMO	1.24	1.30	+4.8%	124.55	-5.0%	-7.1%	-6.2%	-3.9%	-2.5%	-4.6%	+2.2%	—
Apr 25, 2024	BMO	1.12	1.14	+1.8%	123.27	-7.5%	-9.8%	-11.1%	-7.1%	-9.4%	-10.9%	-1.5%	—
Feb 15, 2024	BMO	1.34	1.39	+3.7%	105.05	-1.4%	-5.0%	-5.4%	-4.5%	-6.1%	-4.6%	+8.0%	—
Oct 26, 2023	BMO	1.05	1.27	+21.0%	69.42	+5.7%	+15.6%	+13.6%	+15.8%	+16.9%	+18.7%	+29.9%	—
Jul 27, 2023	BMO	0.99	1.14	+15.2%	86.99	+5.7%	+7.2%	+5.5%	+6.3%	+6.5%	+6.2%	-5.7%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	Piper Sandler	Maintains	Overweight → Overweight	—	$88.51	$87.85	-0.7%	-5.1%	—	—	—	—
May 1	Citigroup	Maintains	Neutral → Neutral	—	$88.51	$87.85	-0.7%	-5.1%	—	—	—	—
Feb 20	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$83.00	$83.00	+0.0%	+2.2%	+3.3%	+4.9%	+4.2%	+4.5%
Feb 20	Truist	Maintains	Buy → Buy	—	$83.00	$83.00	+0.0%	+2.2%	+3.3%	+4.9%	+4.2%	+4.5%
Feb 20	Citigroup	Maintains	Neutral → Neutral	—	$83.00	$83.00	+0.0%	+2.2%	+3.3%	+4.9%	+4.2%	+4.5%
Feb 20	Benchmark	Upgrade	Hold → Buy	—	$83.00	$83.00	+0.0%	+2.2%	+3.3%	+4.9%	+4.2%	+4.5%
Dec 18	Truist	Maintains	Buy → Buy	—	$74.13	$76.00	+2.5%	+5.9%	+6.0%	+6.9%	+4.9%	+6.2%
Dec 11	Citigroup	Maintains	Neutral → Neutral	—	$71.95	$72.13	+0.3%	+0.5%	+1.1%	+1.6%	+2.7%	+3.0%
Nov 24	Truist	Maintains	Buy → Buy	—	$70.00	$69.93	-0.1%	+1.7%	+2.0%	+2.9%	+3.1%	+2.5%
Nov 3	Citigroup	Maintains	Neutral → Neutral	—	$64.57	$64.57	+0.0%	+3.7%	+6.3%	+5.5%	+3.2%	+5.7%
Oct 24	Piper Sandler	Maintains	Overweight → Overweight	—	$73.89	$71.57	-3.1%	-1.3%	-5.0%	-8.0%	-11.6%	-14.3%
Oct 24	Raymond James	Maintains	Outperform → Outperform	—	$73.89	$71.57	-3.1%	-1.3%	-5.0%	-8.0%	-11.6%	-14.3%
Oct 24	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$73.89	$71.57	-3.1%	-1.3%	-5.0%	-8.0%	-11.6%	-14.3%
Oct 24	Benchmark	Downgrade	Buy → Hold	—	$73.89	$71.57	-3.1%	-1.3%	-5.0%	-8.0%	-11.6%	-14.3%
Oct 24	Truist	Maintains	Buy → Buy	—	$73.89	$71.57	-3.1%	-1.3%	-5.0%	-8.0%	-11.6%	-14.3%
Oct 24	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$73.89	$71.57	-3.1%	-1.3%	-5.0%	-8.0%	-11.6%	-14.3%
Oct 24	Citigroup	Downgrade	Buy → Neutral	—	$73.89	$71.57	-3.1%	-1.3%	-5.0%	-8.0%	-11.6%	-14.3%
Oct 21	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$107.37	$106.40	-0.9%	+0.5%	+1.6%	-31.2%	-32.1%	-34.6%
Oct 15	Truist	Maintains	Buy → Buy	—	$103.97	$103.32	-0.6%	-0.2%	-0.8%	+0.8%	+3.3%	+3.8%
Jul 25	Raymond James	Maintains	Outperform → Outperform	—	$107.10	$107.10	+0.0%	+1.3%	+1.0%	+2.0%	+1.6%	+1.3%
Jul 25	Truist	Maintains	Buy → Buy	—	$107.10	$107.10	+0.0%	+1.3%	+1.0%	+2.0%	+1.6%	+1.3%
Jul 25	Wells Fargo	Maintains	Overweight → Overweight	—	$107.10	$107.10	+0.0%	+1.3%	+1.0%	+2.0%	+1.6%	+1.3%
May 22	Citigroup	Upgrade	Neutral → Buy	—	$118.88	$120.07	+1.0%	-0.6%	-0.5%	+2.3%	+0.4%	+0.5%
Apr 28	Truist	Maintains	Buy → Buy	—	$123.41	$123.41	+0.0%	-0.5%	+2.9%	+2.3%	+1.8%	+1.8%
Apr 25	Raymond James	Maintains	Outperform → Outperform	—	$121.46	$121.59	+0.1%	+1.6%	+1.1%	+4.5%	+4.0%	+3.4%
Apr 25	Benchmark	Maintains	Buy → Buy	—	$121.46	$121.59	+0.1%	+1.6%	+1.1%	+4.5%	+4.0%	+3.4%
Apr 21	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$116.98	$115.87	-0.9%	-1.3%	+0.9%	+3.0%	+3.8%	+5.5%
Apr 11	Truist	Maintains	Buy → Buy	—	$113.83	$113.85	+0.0%	+2.3%	+3.6%	+2.7%	+2.1%	+2.8%
Feb 21	Benchmark	Maintains	Buy → Buy	—	$135.22	$135.73	+0.4%	-4.0%	-6.1%	-5.5%	-6.6%	-8.4%
Feb 20	Citigroup	Maintains	Neutral → Neutral	—	$143.21	$142.00	-0.8%	-5.6%	-9.3%	-11.3%	-10.8%	-11.8%
Jan 24	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$143.28	$142.50	-0.5%	-0.6%	-0.1%	+0.8%	-0.0%	+0.2%
Dec 11	Citigroup	Maintains	Neutral → Neutral	—	$139.64	$141.04	+1.0%	+0.7%	-0.3%	-0.7%	-0.9%	-2.1%
Dec 11	Truist	Maintains	Buy → Buy	—	$139.64	$141.04	+1.0%	+0.7%	-0.3%	-0.7%	-0.9%	-2.1%
Oct 25	Piper Sandler	Maintains	Overweight → Overweight	—	$126.76	$128.63	+1.5%	-0.8%	+0.9%	+2.6%	+2.5%	-2.0%
Oct 25	Benchmark	Maintains	Buy → Buy	—	$126.76	$128.63	+1.5%	-0.8%	+0.9%	+2.6%	+2.5%	-2.0%
Oct 25	Truist	Maintains	Buy → Buy	—	$126.76	$128.63	+1.5%	-0.8%	+0.9%	+2.6%	+2.5%	-2.0%
Oct 21	Benchmark	Maintains	Buy → Buy	—	$130.43	$130.10	-0.3%	-2.0%	-3.7%	-3.0%	-2.8%	-3.6%
Oct 15	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$132.43	$132.32	-0.1%	-0.7%	-1.0%	-1.5%	-1.5%	-3.5%
Oct 14	Truist	Maintains	Buy → Buy	—	$129.24	$130.14	+0.7%	+2.5%	+1.7%	+1.4%	+0.9%	+0.9%
Oct 2	Benchmark	Maintains	Buy → Buy	—	$127.19	$126.43	-0.6%	+0.0%	-1.1%	+1.5%	+1.2%	+1.6%
Oct 1	BofA Securities	Maintains	Buy → Buy	—	$130.00	$130.49	+0.4%	-2.2%	-2.1%	-3.2%	-0.7%	-1.0%
Oct 1	Truist	Maintains	Buy → Buy	—	$130.00	$130.49	+0.4%	-2.2%	-2.1%	-3.2%	-0.7%	-1.0%
Oct 1	Citigroup	Maintains	Neutral → Neutral	—	$130.00	$130.49	+0.4%	-2.2%	-2.1%	-3.2%	-0.7%	-1.0%
Aug 2	Benchmark	Maintains	Buy → Buy	—	$116.16	$113.69	-2.1%	-3.8%	-5.1%	-3.2%	-2.7%	-1.4%
May 22	Citigroup	Maintains	Neutral → Neutral	—	$121.31	$121.39	+0.1%	+0.2%	+0.4%	+1.1%	+0.1%	+0.1%
May 10	Benchmark	Maintains	Buy → Buy	—	$114.23	$114.40	+0.1%	-0.2%	-1.3%	-1.9%	+3.1%	+4.2%
Apr 26	Benchmark	Maintains	Buy → Buy	—	$111.15	$110.54	-0.5%	-1.4%	+3.1%	+0.4%	-1.2%	-1.1%
Apr 15	BofA Securities	Upgrade	Neutral → Buy	—	$115.77	$118.68	+2.5%	+2.5%	+3.1%	+2.4%	+1.8%	+0.7%
Apr 9	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$115.40	$117.52	+1.8%	+3.1%	+0.1%	+1.4%	+0.3%	+2.8%
Mar 28	Benchmark	Maintains	Buy → Buy	—	$115.06	$116.70	+1.4%	+1.4%	+0.8%	-0.4%	+1.0%	-0.0%

Recent Filings

8-K · 7.01 ! Medium

Integer Holdings Corporation -- 8-K 7.01: Regulation FD Disclosure

Integer Holdings Corporation's board initiated a strategic review process to evaluate options for maximizing shareholder value, signaling potential significant corporate actions ahead.

Apr 30

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

The departure of an executive at Integra LifeSciences (ITGR) signals potential leadership instability and may create near-term uncertainty around strategic direction and operational continuity.

Mar 12

8-K · 7.01 ! Medium

Integer Holdings Corporation -- 8-K 7.01: Regulation FD Disclosure

Integer Holdings Corporation disclosed non-binding information via Regulation FD, indicating the company shared material details with investors but avoided formal filing obligations under securities law.

Feb 19

Data updated apr 25, 2026 4:23pm · Source: massive.com